Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Renée Fortner

Head of Division

Deutsches Krebsforschungszentrum

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Epidemiology Epidemiology professors in Germany

Articles (18)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Marcela Guevara

Instituto de Salud Pública de Navarra

SPAIN

View details

Solveig Hofvind

professor

UiT Norges arktiske universitet

NORWAY

View details

Kathryn Terry

Co-Scientific Director

Boston Children's Hospital

UNITED STATES

View details

Leila Lujan-Barroso

Associate professor

University of Barcelona

SPAIN

View details

Luca Pestarino

Norwegian Institute of Public Health

NORWAY

View details

Oluf Dimitri Røe

Professor

Aalborg Universitet Det Sundhedsvidenskabelige Fakultet

DENMARK

View details

Ilona Urbarova

Researcher

UiT The Arctic University of Norway

NORWAY

View details

Johannes Alois Vey

University Hospital Heidelberg

GERMANY

View details

Sabine Behrens

Deutsches Krebsforschungszentrum

GERMANY

View details

Trine Rounge

Professor

University of Oslo

NORWAY

View details

Siri Vangen

Professor ll

University of Oslo

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Renée Fortner

Research Interests

Explore related searches

Articles (18)

Proteomic Profiling Using a Proximity Extension Assay Panel on Serum Samples Stored at −25°C Over Several Decades

Ovarian cancer survival in Germany: a nationwide analysis by stage and histotype

Diabetes-Related Dietary Patterns and Endometrial Cancer Risk and Survival in the European Prospective Investigation into Cancer and Nutrition Study

Recommendations for Validating Omics Prediction Models: Insights from a Lung Cancer RNA Biomarker Study

Correction: Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway

Thyroid hormones and epithelial ovarian cancer risk and survival: results from the European Prospective Investigation into Cancer and Nutrition study

Ovarian cancer survival by residual disease following cytoreductive surgery: a nationwide study in Norway

Statins and the risk of gynecological cancer: a Norwegian population-based cohort study

Low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs and epithelial ovarian cancer survival: a registry-based cohort study in Norway

A Prospective Study Consortium for the Discovery and Validation of Early Detection Markers for Ovarian Cancer ("PREDICT") - Baseline findings for CA125.

Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway

Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses’ Health Studies

Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort

Circulating oxysterols and prognosis among women with a breast cancer diagnosis: results from the MARIE patient cohort

Sexually Transmitted Infections and Risk of Epithelial Ovarian Cancer: Results From the Finnish Maternity Cohort

Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway

Association of circulating free and total oxysterols in breast cancer patients

Physical activity and breast cancer survival: results from the Nurses’ Health Studies

Collaborators (11)

Marcela Guevara

Solveig Hofvind

Kathryn Terry

Leila Lujan-Barroso

Luca Pestarino

Oluf Dimitri Røe

Ilona Urbarova

Johannes Alois Vey

Sabine Behrens

Trine Rounge

Siri Vangen

Make your next move.